161 related articles for article (PubMed ID: 36079127)
1. Immunohistochemical Expression of CD44, MMP-2, MMP-9, and Ki-67 as the Prognostic Markers in Non-Clear Cell Renal Cell Carcinomas-A Prospective Cohort Study.
Chrabańska M; Rynkiewicz M; Kiczmer P; Drozdzowska B
J Clin Med; 2022 Sep; 11(17):. PubMed ID: 36079127
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical expression of CD44, matrix metalloproteinase2 and matrix metalloproteinase9 in renal cell carcinomas.
Lee YM; Kim JM; Lee HJ; Seong IO; Kim KH
Urol Oncol; 2019 Oct; 37(10):742-748. PubMed ID: 31053527
[TBL] [Abstract][Full Text] [Related]
3. Does the Immunohistochemical Expression of CD44, MMP-2, and MMP-9 in Association with the Histopathological Subtype of Renal Cell Carcinoma Affect the Survival of Patients with Renal Cancer?
Chrabańska M; Rynkiewicz M; Kiczmer P; Drozdzowska B
Cancers (Basel); 2023 Feb; 15(4):. PubMed ID: 36831550
[TBL] [Abstract][Full Text] [Related]
4. Increased expression of matrix metalloproteinase 9 correlates with poor prognostic variables in renal cell carcinoma.
Cho NH; Shim HS; Rha SY; Kang SH; Hong SH; Choi YD; Hong SJ; Cho SH
Eur Urol; 2003 Nov; 44(5):560-6. PubMed ID: 14572755
[TBL] [Abstract][Full Text] [Related]
5. Increased expression of matrix metalloproteinases 2 and 9 and tissue inhibitors of metalloproteinases 1 and 2 correlate with poor prognostic variables in renal cell carcinoma.
Kallakury BV; Karikehalli S; Haholu A; Sheehan CE; Azumi N; Ross JS
Clin Cancer Res; 2001 Oct; 7(10):3113-9. PubMed ID: 11595703
[TBL] [Abstract][Full Text] [Related]
6. [Clinicopathologic and molecular genetic study of renal cell carcinoma occurring in teenagers].
Rao Q; Zhou J; Zhang RS; Ma HH; Zhou HB; Lu ZF; Zhou XJ
Zhonghua Bing Li Xue Za Zhi; 2010 Sep; 39(9):582-6. PubMed ID: 21092583
[TBL] [Abstract][Full Text] [Related]
7. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
Rabjerg M
Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
[TBL] [Abstract][Full Text] [Related]
8. Papillary (chromophil) renal cell carcinoma: histomorphologic characteristics and evaluation of conventional pathologic prognostic parameters in 62 cases.
Amin MB; Corless CL; Renshaw AA; Tickoo SK; Kubus J; Schultz DS
Am J Surg Pathol; 1997 Jun; 21(6):621-35. PubMed ID: 9199639
[TBL] [Abstract][Full Text] [Related]
9. Expanding the morphologic spectrum of chromophobe renal cell carcinoma: A study of 8 cases with papillary architecture.
Michalova K; Tretiakova M; Pivovarcikova K; Alaghehbandan R; Perez Montiel D; Ulamec M; Osunkoya A; Trpkov K; Yuan G; Grossmann P; Sperga M; Ferak I; Rogala J; Mareckova J; Pitra T; Kolar J; Michal M; Hes O
Ann Diagn Pathol; 2020 Feb; 44():151448. PubMed ID: 31918172
[TBL] [Abstract][Full Text] [Related]
10. Prognostic role of CD44 cell adhesion molecule expression in primary and metastatic renal cell carcinoma: a clinicopathologic study of 125 cases.
Lim SD; Young AN; Paner GP; Amin MB
Virchows Arch; 2008 Jan; 452(1):49-55. PubMed ID: 18026989
[TBL] [Abstract][Full Text] [Related]
11. Clear cell renal cell carcinoma: discrimination from other renal cell carcinoma subtypes and oncocytoma at multiphasic multidetector CT.
Young JR; Margolis D; Sauk S; Pantuck AJ; Sayre J; Raman SS
Radiology; 2013 May; 267(2):444-53. PubMed ID: 23382290
[TBL] [Abstract][Full Text] [Related]
12. Increased expression of CD44 is associated with more aggressive behavior in clear cell renal cell carcinoma.
Zanjani LS; Madjd Z; Abolhasani M; Rasti A; Fodstad O; Andersson Y; Asgari M
Biomark Med; 2018 Jan; 12(1):45-61. PubMed ID: 29243496
[TBL] [Abstract][Full Text] [Related]
13. Glutathione peroxidase family and survival prognosis in patients with renal cell carcinoma.
Li J; Huo S; Zhang R; Shi C; Sun N; Liu Q
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 May; 47(5):562-572. PubMed ID: 35753726
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Factors for Renal Cell Carcinoma Subtypes Diagnosed According to the 2016 WHO Renal Tumor Classification: a Study Involving 928 Patients.
Kuthi L; Jenei A; Hajdu A; Németh I; Varga Z; Bajory Z; Pajor L; Iványi B
Pathol Oncol Res; 2017 Jul; 23(3):689-698. PubMed ID: 28032311
[TBL] [Abstract][Full Text] [Related]
15. Claudin-7 immunohistochemistry in renal tumors: a candidate marker for chromophobe renal cell carcinoma identified by gene expression profiling.
Hornsby CD; Cohen C; Amin MB; Picken MM; Lawson D; Yin-Goen Q; Young AN
Arch Pathol Lab Med; 2007 Oct; 131(10):1541-6. PubMed ID: 17922590
[TBL] [Abstract][Full Text] [Related]
16. Quantitative immunohistochemical analysis of matrilysin 1 (MMP-7) in various renal cell carcinoma subtypes.
Patraki E; Cardillo MR
Int J Immunopathol Pharmacol; 2007; 20(4):697-705. PubMed ID: 18179742
[TBL] [Abstract][Full Text] [Related]
17. C-kit expression in renal oncocytomas and chromophobe renal cell carcinomas.
Huo L; Sugimura J; Tretiakova MS; Patton KT; Gupta R; Popov B; Laskin WB; Yeldandi A; Teh BT; Yang XJ
Hum Pathol; 2005 Mar; 36(3):262-8. PubMed ID: 15791570
[TBL] [Abstract][Full Text] [Related]
18. Clinical symptoms in localized renal cell carcinoma reflect its invasive potential: comparative study between incidentally detected and symptomatic diseases.
Harada K; Sakai I; Ishimura T; Inoue TA; Hara I; Miyake H
Urol Oncol; 2006; 24(3):201-6. PubMed ID: 16678049
[TBL] [Abstract][Full Text] [Related]
19. Effect of papillary and chromophobe cell type on disease-free survival after nephrectomy for renal cell carcinoma.
Beck SD; Patel MI; Snyder ME; Kattan MW; Motzer RJ; Reuter VE; Russo P
Ann Surg Oncol; 2004 Jan; 11(1):71-7. PubMed ID: 14699037
[TBL] [Abstract][Full Text] [Related]
20. Performance of Relative Enhancement on Multiphasic MRI for the Differentiation of Clear Cell Renal Cell Carcinoma (RCC) From Papillary and Chromophobe RCC Subtypes and Oncocytoma.
Young JR; Coy H; Kim HJ; Douek M; Lo P; Pantuck AJ; Raman SS
AJR Am J Roentgenol; 2017 Apr; 208(4):812-819. PubMed ID: 28125273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
